Ethyl 4-[4-(difluoromethoxy)phenyl]-2-methyl-5-oxo-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate, with the CAS number 92638-14-7, is a synthetic organic compound characterized by its complex molecular structure, which includes a pyridine ring fused with a furo[3,4-b] moiety. This compound features a carboxylate ester functional group, contributing to its potential reactivity and solubility properties. The presence of a difluoromethoxy group enhances its lipophilicity and may influence its biological activity. Typically, compounds of this nature are investigated for their pharmacological properties, including potential applications in medicinal chemistry. The structural intricacies suggest that it may exhibit specific interactions with biological targets, making it a candidate for further research in drug development. Additionally, the compound's stability, solubility, and reactivity can be influenced by the substituents on the aromatic rings and the overall molecular conformation. As with many synthetic compounds, safety and handling precautions are essential when working with this substance in a laboratory setting.

ethyl 4-[4-(difluoromethoxy)phenyl]-2-methyl-5-oxo-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate

92638-14-7: Furo(3,4-b)pyridine-3-carboxylic acid, 4-(4-(difluoromethoxy)phenyl)-1,4,5,7-tetrahydro-2-methyl-5-oxo-, ethyl ester

Ethyl 5-[4-(difluoromethoxy)phenyl]-3-methyl-7-oxo-8-oxa-2-azabicyclo[4.3.0]nona-3,10-diene-4carboxylate (EFD) is a synthetic compound that interacts with calcium channels in the muscle cell membrane and modulates the flow of calcium ions through the channel. This interaction leads to an increase in intracellular calcium concentrations, which can activate protein kinase C and modify ion transport system function. EFD has been shown to be effective against neuroblastoma cells, as well as reticulum and sarcoplasmic reticulum cells. It also has an antagonistic effect on the ryanodine receptors in these cells, leading to increased release of calcium from storage sites within the cell.

Ethyl 5-[4-(Difluoromethoxy)Phenyl]-3-Methyl-7-Oxo-8-Oxa-2-Azabicyclo[ 4.3.0]Nona-3,10-Diene-4-Carboxylate

Cgp 28861 reverses the effects of calcium channel blockaders in the frog heart.

CAS 92638-14-7: ethyl 4-[4-(difluoromethoxy)phenyl]-2-methyl-5-oxo-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate

Ethyl 5-[4-(Difluoromethoxy)Phenyl]-3-Methyl-7-Oxo-8-Oxa-2-Azabicyclo[ 4.3.0]Nona-3,10-Diene-4-Carboxylate

Ref: 3D-FE102814

Cgp 28861

Ref: TM-T30823